Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: Relationship to anhedonia

Archives of General Psychiatry

Volumn 69, Issue 2, 2012, Pages 139-149

  Gabbay, Vilma ^a,c   Mao, Xiangling ^b   Klein, Rachel G ^a   Ely, Benjamin A ^a   Babb, James S ^a   Panzer, Aviva M ^a   Alonso, Carmen M ^a   Shungu, Dikoma C ^b  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; WATER;

ADOLESCENT; ADULT; ANHEDONIA; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; SCORING SYSTEM;

ADOLESCENT; ANHEDONIA; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROIMAGING; NEUROTRANSMITTER AGENTS; YOUNG ADULT;

EID: 84856749803     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.131     Document Type: Article

References (68)

1. Andrews G, Brugha T, Thase ME, Duffy FF, Rucci P, Slade T. Dimensionality and the category of major depressive episode. Int J Methods Psychiatr Res. 2007;16(suppl 1):S41-S51. (Pubitemid 46930452)
2. Widiger TA, Samuel DB. Diagnostic categories or dimensions? a question for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition. J Abnorm Psychol. 2005;114(4):494-504. (Pubitemid 41746988)
3. Ryan ND, Puig-Antich J, Ambrosini P, Rabinovich H, Robinson D, Nelson B, Iyengar S, Twomey J. The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry. 1987;44(10):854-861. (Pubitemid 17155442)
4. Klein RG, Mannuzza S, Koplewicz HS, Tancer NK, Shah M, Liang V, Davies M. Adolescent depression: controlled desipramine treatment and atypical features. Depress Anxiety. 1998;7(1):15-31. (Pubitemid 28248516)
5. Yorbik O, Birmaher B, Axelson D, Williamson DE, Ryan ND. Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder. J Clin Psychiatry. 2004;65(12):1654-1659.
6. Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology. 2009;34(5):1277-1287.
7. Yüksel C, Öngür D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry. 2010;68(9):785-794.
8. Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2011;16(4):383-406.
9. Tordera RM, Garcia-García AL, Elizalde N, Segura V, Aso E, Venzala E, Ramírez MJ, Del Rio J. Chronic stress and impaired glutamate function elicit a depressivelike phenotype and common changes in gene expression in the mouse frontal cortex. Eur Neuropsychopharmacol. 2011;21(1):23-32.
10. Shen Q, Lal R, Luellen BA, Earnheart JC, Andrews AM, Luscher B. gamma- Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitaryadrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol Psychiatry. 2010;68(6):512-520.
11. Roy A, Dejong J, Ferraro T. CSF GABA in depressed patients and normal controls. Psychol Med. 1991;21(3):613-618.
12. Petty F, Kramer GL, Gullion CM, Rush AJ. Low plasma gamma-aminobutyric acid levels in male patients with depression. Biol Psychiatry. 1992;32(4):354-363.
13. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry. 2004;61 (7):705-713. (Pubitemid 38890805)
14. Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, Schnepf B, Boeker H, Boesiger P, Northoff G. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry. 2009;66(5):478-486.
15. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT. Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 1997;8(4):1057-1061. (Pubitemid 27152174)
16. Drevets WC, Ongür D, Price JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry. 1998;3(3):220-226, 190-191.
17. Botteron KN, Raichle ME, Drevets WC, Heath AC, Todd RD. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry. 2002;51(4):342-344. (Pubitemid 34215000)
18. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651-660. (Pubitemid 40320700)
19. Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47(4):305-313. (Pubitemid 30109243)
20. Gruber S, Frey R, Mlynárik V, Stadlbauer A, Heiden A, Kasper S, Kemp GJ, Moser E. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol. 2003;38(7):403-408. (Pubitemid 36791333)
21. Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS. Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry. 2005;57(12):1526-1534. (Pubitemid 40805382)
22. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64(2):193-200. (Pubitemid 46220776)
23. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 2004;43(9):1146-1153. (Pubitemid 39096872)
24. Mirza Y, Tang J, Russell A, Banerjee SP, Bhandari R, Ivey J, Rose M, Moore GJ, Rosenberg DR. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry. 2004;43(3):341-348. (Pubitemid 41615014)
25. Pizzagalli DA, Jahn AL, O'Shea JP. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry. 2005;57(4):319-327. (Pubitemid 40215760)
26. Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537-555.
27. Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S, Busto UE. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry. 2005;62(11):1228-1236. (Pubitemid 41586922)
28. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Boorman E, Matthews PM, Cowen PJ. Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol. 2008;11(2):255-260. (Pubitemid 351231824)
29. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988. (Pubitemid 27272932)
30. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997;35(8):785-791. (Pubitemid 27336913)
31. Joiner TE, Brown JS, Metalsky GI. A test of the tripartite model's prediction of anhedonia's specificity to depression: patients with major depression versus patients with schizophrenia. Psychiatry Res. 2003;119(3):243-250. (Pubitemid 36952604)
32. Leventhal AM, Chasson GS, Tapia E, Miller EK, Pettit JW. Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales. J Clin Psychol. 2006;62(12):1545-1558. (Pubitemid 44862645)
33. Rothman DL, Petroff OAC, Behar KL, Mattson RH. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A. 1993;90(12):5662-5666. (Pubitemid 23176221)
34. Sailasuta N, LeRoux P, Hurd R, Wang P, Sachs N, Ketter T. Detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers at 3 T. In: Proceedings of the ISMRM Annual Meeting. Vol 6. Berkeley, CA: ISMRM; 2001:1011.
35. Geramita M, van der Veen JW, Barnett AS, Savostyanova AA, Shen J, Weinberger DR, Marenco S. Reproducibility of prefrontal γ-aminobutyric acid measurements with J-edited spectroscopy [published online February 3, 2011]. NMR Biomed. doi:10.1002/nbm.1662.
36. Brown MA. Time-domain combination of MR spectroscopy data acquired using phased-array coils. Magn Reson Med. 2004;52(5):1207-1213. (Pubitemid 39453296)
37. Markwardt CB. Non-linear least squares fitting in IDL with MPFIT. In: Proceedings of Astronomical Data Analysis Software and Systems XVIII 2008. Vol 411. San Francisco, CA: Astronomical Society of the Pacific; 2009:251-254.
38. Marshall I, Bruce SD, Higinbotham J, MacLullich A, Wardlaw JM, Ferguson KJ, Seckl J. Choice of spectroscopic lineshape model affects metabolite peak areas and area ratios. Magn Reson Med. 2000;44(4):646-649.
39. Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med. 1994;32(3):294-302. (Pubitemid 24274907)
40. Behar KL, Ogino T. Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain. Magn Reson Med. 1993;30(1):38-44. (Pubitemid 23203794)
41. Hetherington HP, Pan JW, Mason GF, Adams D, Vaughn MJ, Twieg DB, Pohost GM. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med. 1996;36(1):21-29. (Pubitemid 26196527)
42. Maudsley AA, Darkazanli A, Alger JR, Hall LO, Schuff N, Studholme C, Yu Y, Ebel A, Frew A, Goldgof D, Gu Y, Pagare R, Rousseau F, Sivasankaran K, Soher BJ, Weber P, Young K, Zhu X. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed. 2006;19(4):492-503. (Pubitemid 43997768)
43. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 1999;56(11):1043-1047. (Pubitemid 29526389)
44. Rajkowska G, O'Dwyer G, Teleki Z, Stockmeier CA, Miguel-Hidalgo JJ. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology. 2007;32(2):471-482. (Pubitemid 46106953)
45. Karolewicz B, Maciag D, O'Dwyer G, Stockmeier CA, Feyissa AM, Rajkowska G. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol. 2010;13(4):411-420.
46. Gos T, Günther K, Bielau H, Dobrowolny H, Mawrin C, Trübner K, Brisch R, Steiner J, Bernstein HG, Jankowski Z, Bogerts B. Suicide and depression in the quantitative analysis of glutamic acid decarboxylase- immunoreactive neuropil. J Affect Disord. 2009;113(1-2):45-55.
47. Chertkow Y, Weinreb O, Youdim MB, Silver H. The effect of chronic coadministration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex. Int J Neuropsychopharmacol. 2006;9(3):287-296. (Pubitemid 43780496)
48. Silver H, Chertkow Y, Weinreb O, Danovich L, Youdim M. Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia? Neurotherapeutics. 2009;6(1):86-93.
49. Kraemer HC, Noda A, O'Hara R. Categorical versus dimensional approaches to diagnosis: methodological challenges. J Psychiatr Res. 2004;38(1):17-25. (Pubitemid 38018986)
50. Price RB, Mathew SJ, Mao X, Nestadt P, Kelly C, Collins KA, Murrough J, Shungu DC. Decreased GABA concentrations in patients with treatment resistant depression: a proton magnetic resonance spectroscopy study [abstract]. Biol Psychiatry. 2008;63(7):300S Abstract 947.
51. Hancu I, Port J. The case of the missing glutamine. NMR Biomed. 2011;24(5):529-535.
52. Binesh N, Kumar A, Hwang S, Mintz J, Thomas MA. Neurochemistry of late-life major depression: a pilot two-dimensional MR spectroscopic study. J Magn Reson Imaging. 2004;20(6):1039-1045. (Pubitemid 39577907)
53. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev. 2009;61(2):105-123.
54. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98(3):641-653. (Pubitemid 44051266)
55. Bechtholt-Gompf AJ, Walther HV, Adams MA, Carlezon WA Jr, Ongür D, Cohen BM. Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology. 2010;35(10):2049-2059.
56. Elizalde N, García-García AL, Totterdell S, Gendive N, Venzala E, Ramirez MJ, Del Rio J, Tordera RM. Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacology (Berl). 2010;210(3):393-406.
57. Steiniger B, Kretschmer BD. Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus. Exp Brain Res. 2003;149(4):422-430. (Pubitemid 36458032)
58. Castañeda TR, de Prado BM, Prieto D, Mora F. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res. 2004;36(3):177-185. (Pubitemid 38429283)
59. Marquez de Prado B, Castañeda TR, Galindo A, del Arco A, Segovia G, Reiter RJ, Mora F. Melatonin disrupts circadian rhythms of glutamate and GABA in the neostriatum of the aware rat: a microdialysis study. J Pineal Res. 2000;29(4):209-216.
60. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry. 2006;59(12):1151-1159. (Pubitemid 44192421)
61. Rodrigues TB, Granado N, Ortiz O, Cerdán S, Moratalla R. Metabolic interactions between glutamatergic and dopaminergic neurotransmitter systems are mediated through D(1) dopamine receptors. J Neurosci Res. 2007;85(15):3284-3293. (Pubitemid 350058516)
62. Bielau H, Steiner J, Mawrin C, Trübner K, Brisch R, Meyer-Lotz G, Brodhun M, Dobrowolny H, Baumann B, Gos T, Bernstein HG, Bogerts B. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study. Ann N Y Acad Sci. 2007;1096:157-169. (Pubitemid 47092509)
63. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry. 2007;61(6):806-812. (Pubitemid 46330250)
64. Wu F, Tang Y, Xu K, Kong L, Sun W, Wang F, Kong D, Li Y, Liu Y. Whiter matter abnormalities in medication-naive subjects with a single short-duration episode of major depressive disorder. Psychiatry Res. 2011;191(1):80-83.
65. Steingard RJ, Renshaw PF, Hennen J, Lenox M, Cintron CB, Young AD, Connor DF, Au TH, Yurgelun-Todd DA. Smaller frontal lobe white matter volumes in depressed adolescents. Biol Psychiatry. 2002;52(5):413-417. (Pubitemid 35266732)
66. Peterson BS, Weissman MM. A brain-based endophenotype for major depressive disorder. Annu Rev Med. 2011;62:461-474.
67. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67(2-3):269-275. (Pubitemid 38251458)
68. Korgaonkar MS, Grieve SM, Koslow SH, Gabrieli JD, Gordon E, Williams LM. Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging [published online December 17, 2010]. Hum Brain Mapp. doi:10.1002/hbm.21178.